Skip to main content

Parkinson’s Disease as a Model for Behavioural Studies in Man

  • Chapter
Transmitter Biochemistry of Human Brain Tissue
  • 134 Accesses

Abstract

The progress of medical science depends on the connection and cooperation of clinical observation and basic research. A success story of this cooperation is found in the understanding and treatment of Parkinson’s disease where observations in the clinic were correlated with findings of decreased dopamine (DA) concentrations in post mortem brain (Ehringer and Hornykiewicz, 1960). Animal studies first identified DA as a neurotransmitter, and further such studies were preliminary to clinical treatment with L-dopa (Birkmayer and Hornykiewicz, 1961; Barbeau et al., 1961).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barbeau, A., Murphy, G.F., Sourkes T.L. (1961) Excretion of Dopamine in Diseases of Basal Ganglia Science 133, 1706

    Google Scholar 

  • Birkmayer, W., Hornykiewicz, O. (1961) Der L-3,4-Dioxyphenylalanin (=Dopa)-Effekt bei der Parkinson-Akinese. Wien.klin.Wschr. 73, 787

    Google Scholar 

  • Birkmayer, W., Neumayer, E., (1972) Die Behandlung der Dopa-Psychosen mit L-Tryptophan. Nervenarzt 43, 76

    Google Scholar 

  • Birkmayer, W., Neumayer, E. (1963). Die Wärmeregulation beim postencephalitischen Parkinsonismus. Nervenarzt 34, 373.

    Google Scholar 

  • Birkmayer, W., Jellinger, K., Riederer, P. (1977) Striatal and Extrastriatal Dopaminergic Functions. In Psychobiology of the Striatum (eds. A.R.Cools, A.H.M.Lohman and J.H.L.van den Bercken) North-Holland, Amsterdam-New York-Oxford; pp 141

    Google Scholar 

  • Birkmayer, W., Riederer, P., Youdim M.B.H. (1979) Distinction between Benign and Malignant Type of Parkinson’s Disease. Clin.Neurol.Neurosurg. 81, 158

    Article  Google Scholar 

  • Birkmayer, W., Riederer P. (1980) Die Parkinson-Krankheit. Springer Verlag Wien — New York

    Book  Google Scholar 

  • Coppen, A., Shaw, D.M., Herzberg, B., Maggs R. (1967) Tryptophan in the Treatment of Depression. Lancet ii, 1178

    Article  Google Scholar 

  • Ehringer, H., Hornykiewicz, O., (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten der Erkrankungen des extrapyramidalen Systems. Klin.Wschr.38, 1236

    Article  Google Scholar 

  • Riederer, P., Birkmayer, W. (1980) A New Concept: Brain Area Specific Imbalance of Neurotransmitters in Depression Syndrome — Human Brain Studies. In Enzymes and Neurotransmitters in Mental Disease (eds. E.Usdin, T.L.Sourkes, and M.B.H.Youdim) John Wiley, New York

    Google Scholar 

  • Schildkraut, J.J., Green, R., Gordon, E.K., Durell, J. (1966) Normetanephrine Excretion and Affective State in Depressed Patients Treated with Imipramine. Amer.J.Psych. 123, 690

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1981 The Contributors

About this chapter

Cite this chapter

Birkmayer, W., Riederer, P. (1981). Parkinson’s Disease as a Model for Behavioural Studies in Man. In: Riederer, P., Usdin, E. (eds) Transmitter Biochemistry of Human Brain Tissue. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05932-4_19

Download citation

Publish with us

Policies and ethics